May 31st, 2016
A new study published by Canadian researchers in the British Medical Journal (BMJ) has found that patients who use the …
Tags: Actos, Avandia, bladder cancer, BMJ, diabetes
Posted in Actos, HO&P Legal Blog, Pharmaceutical Liability |
January 27th, 2016
Executives with Takeda Pharmaceutical, the manufacturer of Actos, admitted that they had paid physicians to prescribe the drug to patients …
Tags: Actos, bladder cancer, diebetes, False Claims Act, FDA, kickbacks, pre-diabetes, qui tam, Takeda, whistleblowers
Posted in Actos, HO&P Legal Blog, Qui Tam Litigation |
August 31st, 2015
A new study published by the Journal of the American Medical Association (JAMA) has found that the diabetes drug Actos …
Tags: Actos, bladder cancer, diabetes, pancreatic cancer, prostate cancer, Takeda
Posted in Actos, HO&P Legal Blog |
July 20th, 2015
Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits filed by patients who developed bladder cancer …
Tags: Actos, bladder cancer, FDA, MDL, Takeda
Posted in Actos, HO&P Legal Blog |
April 15th, 2015
Takeda Pharmaceutical has reportedly offered $2.2 billion to settle thousands of lawsuits filed against the drug company involving diabetes drug Actos …
Tags: Actos, bladder cancer, FDA, MDL, type 2 diabetes
Posted in Actos, HO&P Legal Blog |